• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病中的体重。美国国立卫生研究院间歇性正压通气试验。

Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial.

作者信息

Wilson D O, Rogers R M, Wright E C, Anthonisen N R

机构信息

Department of Medicine, University of Pittsburgh, Pennsylvania.

出版信息

Am Rev Respir Dis. 1989 Jun;139(6):1435-8. doi: 10.1164/ajrccm/139.6.1435.

DOI:10.1164/ajrccm/139.6.1435
PMID:2658702
Abstract

This study reviews the relationship between body weight, pulmonary function, and survival in the recent clinical trial of intermittent positive pressure breathing (IPPB). We related body weight, expressed as a percent of the ideal (%IBW), to the numerous other features of the disease recorded in this data set. Body weight was directly related to FEV1 (p = 0.0001), so that all subsequent analyses of body weight had to first consider FEV1. Mortality appeared to be influenced by body weight independent of FEV1. In patients with %FEV1 less than 35, mortality increased with decreasing body weight (p = 0.093), and this relationship was stronger in patients with %FEV1 35 to 47 (p = 0.048) and even stronger in patients with %FEV1 greater than 47 (p = 0.007). After adjusting for FEV1, body weight was a powerful positive correlate with exercise capacity (p = 0.0001). Body weight was also inversely related to %TLC (p = 0.0408) after adjusting for FEV1. Body weight was a powerful predictor of diffusing capacity (p = 0.0001) in patients with the same FEV1. These results support the hypothesis that factors related to nutritional status are an independent influence on the course of COPD.

摘要

本研究回顾了近期间歇性正压通气(IPPB)临床试验中体重、肺功能和生存率之间的关系。我们将以理想体重百分比(%IBW)表示的体重与该数据集中记录的疾病的许多其他特征相关联。体重与第一秒用力呼气容积(FEV1)直接相关(p = 0.0001),因此所有后续的体重分析都必须首先考虑FEV1。死亡率似乎受独立于FEV1的体重影响。在第一秒用力呼气容积百分比(%FEV1)小于35的患者中,死亡率随体重下降而增加(p = 0.093),在%FEV1为35至47的患者中这种关系更强(p = 0.048),在%FEV1大于47的患者中甚至更强(p = 0.007)。在对FEV1进行校正后,体重与运动能力呈强正相关(p = 0.0001)。在对FEV1进行校正后,体重与肺总量百分比(%TLC)也呈负相关(p = 0.0408)。在具有相同FEV1的患者中,体重是弥散能力的有力预测指标(p = 0.0001)。这些结果支持了这样一种假设,即与营养状况相关的因素对慢性阻塞性肺疾病(COPD)的病程具有独立影响。

相似文献

1
Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial.慢性阻塞性肺疾病中的体重。美国国立卫生研究院间歇性正压通气试验。
Am Rev Respir Dis. 1989 Jun;139(6):1435-8. doi: 10.1164/ajrccm/139.6.1435.
2
Prognosis in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的预后
Am Rev Respir Dis. 1986 Jan;133(1):14-20. doi: 10.1164/arrd.1986.133.1.14.
3
The National Institutes of Health Intermittent Positive-Pressure Breathing trial: pathology studies. II. Correlation between morphologic findings, clinical findings, and evidence of expiratory air-flow obstruction.美国国立卫生研究院间歇性正压呼吸试验:病理学研究。II. 形态学发现、临床发现与呼气气流阻塞证据之间的相关性。
Am Rev Respir Dis. 1985 Nov;132(5):946-53. doi: 10.1164/arrd.1985.132.5.946.
4
Comparison of intermittent positive pressure breathing and temporary positive expiratory pressure in patients with severe chronic obstructive pulmonary disease.比较间歇正压通气和临时正呼气压力在严重慢性阻塞性肺疾病患者中的应用。
Arch Bronconeumol. 2014 Jan;50(1):18-24. doi: 10.1016/j.arbres.2013.07.019. Epub 2013 Dec 8.
5
The National Institutes of Health Intermittent Positive-Pressure Breathing Trial: pathology studies. IV. The Destructive index.
Am Rev Respir Dis. 1989 Jun;139(6):1439-45. doi: 10.1164/ajrccm/139.6.1439.
6
The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者运动期间作为动脉血氧饱和度下降预测指标的弥散能力
N Engl J Med. 1984 May 10;310(19):1218-21. doi: 10.1056/NEJM198405103101903.
7
Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.吸入性支气管扩张剂可减轻慢性阻塞性肺疾病患者运动期间的动态肺过度充气。
Am J Respir Crit Care Med. 1996 Mar;153(3):967-75. doi: 10.1164/ajrccm.153.3.8630581.
8
Nutritional status and mortality in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的营养状况与死亡率
Am J Respir Crit Care Med. 1996 Mar;153(3):961-6. doi: 10.1164/ajrccm.153.3.8630580.
9
Long-term use of intermittent positive-pressure breathing (IPPB) in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中间歇性正压通气(IPPB)的长期应用。
Am Rev Respir Dis. 1976 Jun;113(6):721-8. doi: 10.1164/arrd.1976.113.6.721.
10
Effect of nutritional status on exercise performance in patients with chronic obstructive pulmonary disease.营养状况对慢性阻塞性肺疾病患者运动表现的影响。
Am Rev Respir Dis. 1989 Dec;140(6):1544-8. doi: 10.1164/ajrccm/140.6.1544.

引用本文的文献

1
The independent and combined effects of smoking and chronic obstructive pulmonary disease on body mass index trajectories.吸烟和慢性阻塞性肺疾病对体重指数轨迹的独立及联合影响。
Sci Rep. 2025 Sep 25;15(1):32883. doi: 10.1038/s41598-025-17270-0.
2
Weight change across adulthood in relation to the risk of COPD.成年期体重变化与慢性阻塞性肺疾病风险的关系。
Environ Health Prev Med. 2025;30:64. doi: 10.1265/ehpm.25-00059.
3
Combined Dietary Intake and Its Association With Pulmonary Function and Chronic Obstructive Pulmonary Disease Risk in Korean Adults: 2016-2018 Korea National Health and Nutrition Examination Survey.
韩国成年人的饮食综合摄入量及其与肺功能和慢性阻塞性肺疾病风险的关联:2016 - 2018年韩国国民健康与营养检查调查
Clin Nutr Res. 2025 Jul 25;14(3):182-190. doi: 10.7762/cnr.2025.14.3.182. eCollection 2025 Jul.
4
Nutritional Support of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病的营养支持
Nutrients. 2025 Mar 26;17(7):1149. doi: 10.3390/nu17071149.
5
Impact of Hyponatraemia at Clinical Stable-State on Survival in Patients with Chronic Obstructive Pulmonary Disease.临床稳定状态下低钠血症对慢性阻塞性肺疾病患者生存的影响
Int J Chron Obstruct Pulmon Dis. 2025 Jan 15;20:127-135. doi: 10.2147/COPD.S488309. eCollection 2025.
6
Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow.未达最佳峰吸气流速的慢性阻塞性肺疾病患者的临床负担。
Can Respir J. 2024 Mar 22;2024:8034923. doi: 10.1155/2024/8034923. eCollection 2024.
7
The impact of pulmonary cachexia on inpatient outcomes: A national study.肺恶病质对住院患者结局的影响:一项全国性研究。
Ann Thorac Med. 2023 Jul-Sep;18(3):156-161. doi: 10.4103/atm.atm_31_23. Epub 2023 Jul 19.
8
Impaired Skeletal Muscle in Patients with Stable Chronic Obstructive Pulmonary Disease (COPD) Compared with Non-COPD Patients.稳定期慢性阻塞性肺疾病(COPD)患者的骨骼肌功能受损与非 COPD 患者相比。
Int J Chron Obstruct Pulmon Dis. 2023 Jul 19;18:1525-1532. doi: 10.2147/COPD.S396728. eCollection 2023.
9
All-Cause, Cardiovascular and Respiratory Mortality in People with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease (COPD) in England: A Cohort Study Using the Clinical Practice Research Datalink (CPRD).在英格兰,2 型糖尿病合并慢性阻塞性肺疾病(COPD)患者的全因、心血管和呼吸道死亡率:一项基于临床实践研究数据库(CPRD)的队列研究。
Int J Chron Obstruct Pulmon Dis. 2023 Jun 13;18:1207-1218. doi: 10.2147/COPD.S407085. eCollection 2023.
10
The role of diet and nutrition in the management of COPD.饮食和营养在 COPD 管理中的作用。
Eur Respir Rev. 2023 Jun 7;32(168). doi: 10.1183/16000617.0003-2023. Print 2023 Jun 30.